BioNTech (NASDAQ:BNTX) reported quarterly earnings of $12.97 per share which beat the analyst consensus estimate of $8.91 by 45.57 percent. This is a 3188.1 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $6.39 billion which beat the analyst consensus estimate of $3.84 billion by 66.54 percent. This is a 13.80K percent increase over sales of $45.99 million the same period last year.
BioNTech Q2 EPS $12.97 Beats $8.91 Estimate, Sales $6.39B Beat $3.84B Estimate
BioNTech (NASDAQ:BNTX) reported quarterly earnings of $12.97 per share which beat the analyst consensus estimate of $8.91 by 45.57 percent. This is a 3188.1 percent increase over losses of $(0.42) per share from the same
